Strides Pharma Science LtdNSE: STAR

Press Release Feb 24 2021

· Issued by Strides Pharma Science Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-24-2021-8

Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2021, titled "Strides receives USFDA approval for Ibuprofen OTC Oral Suspension".

View Attachment

6ix hasn’t read this filing yet.

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases